HitGen-DNA Encoded Library-Drug Discovery
  • Highest
  • Lowest
  • Volume
  • Amount
Up to     Beijing time. There is 15-minute delay in the quoted price.


Basic Information
HitGen is a biotech company focused on lead generation and optimization of innovative drug discovery research process. HitGen has its headquarters based in Chengdu, China. Its core technology is centered around the synthesis and screening of a rapidly expanding and proprietary DNA-encoded compound libraries of novel small and macrocyclic molecules for lead generation.
HitGen Inc.
Stock Code 688222 Registered Capital 400,680,000.00
Registered Address Registered Address Building 1 Floor 3, No.88 South Keyuan Road, Hi-Tech Zone, Chengdu, Sichuan
Main Business DNA encoded libraries screening, customized design and synthesis of DNA encoded library, specialized chemistry & bioscience services, and innovative drug discovery project licensing.

The Board Office is in charge of the information disclosure and investor relations. The secretary of the board is Shiwei Geng.

Tel: +86 28 85197385 E-mail: investors@hitgen.com